Free Trial
BMV:FBT

First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News

About First Trust NYSE Arca Biotechnology Index Fund (BMV:FBT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
688 shs
Market Capitalization
N/A
Assets Under Management
N/A
Dividend Yield
N/A
Net Expense Ratio
0.00%
Aggregate Rating
N/A

ETF Overview

Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter.

FBT ETF News Headlines

3 Biotech ETFs for Diversified Innovation Exposure
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
4 A-Rated Biotech Stock Picks for 2024 Success
See More Headlines

FBT ETF - Frequently Asked Questions

Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust NYSE Arca Biotechnology Index Fund investors own include Garmin (GRMN), Pan American Silver (PAAS), WPP (WPP), AbbVie (ABBV), Amgen (AMGN), Argo Group International (ARGO) and Ginkgo Bioworks (DNA).

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (BMV:FBT) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners